AGM/EGMApr 26, 2026, 05:29 AM
NXTC Sets 2026 Annual Meeting; Seeks Approval for Incentive Plan
AI Summary
NextCure, Inc. announced its 2026 Annual Meeting of Stockholders will be held virtually on June 18, 2026. Stockholders will vote on several key proposals, including the election of two Class I directors, the ratification of Ernst & Young LLP as the independent registered public accounting firm, and an advisory vote on executive compensation. Additionally, stockholders are asked to approve an amendment to the 2019 Omnibus Incentive Plan to increase the number of shares authorized for issuance.
Key Highlights
- NextCure to hold 2026 Annual Meeting of Stockholders virtually on June 18, 2026.
- Stockholders to vote on electing two Class I directors for three-year terms.
- Proposal to ratify Ernst & Young LLP as independent auditor for fiscal year 2026.
- Advisory vote on named executive officer compensation (Say-on-Pay).
- Proposal to approve an Amended and Restated 2019 Omnibus Incentive Plan.
- The plan amendment seeks to increase shares authorized for issuance under the plan.
Price Impact
More from NXTC